Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.032
+0.002 (0.19%)
Jul 24, 2026, 5:29 PM CET

Diamyd Medical AB Financials Overview

Millions SEK. Fiscal year is Sep - Aug.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Revenue
4.125.024.363.752.590.44
Revenue Growth
-25.25%14.92%16.47%44.95%482.21%-99.00%
Gross Profit
4.125.024.363.752.590.44
Operating Income
-287.57-183.24-146.57-120.81-118.18-85.88
Net Income
-283.65-169.78-151.85-116.07-103.5260.05
Earnings Per Share
-1.80-1.50-1.60-1.50-1.400.90
EPS Growth
-----800.00%

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Net Cash (Debt)
346.11277.19132.37127.53159.67139.38
Net Cash Growth
8.41%109.41%3.79%-20.13%14.56%103.88%
Cash & Investments
346.11277.19132.37127.53159.67139.38
Net Cash Per Share
2.462.461.401.632.092.00

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Operating Cash Flow
-190.85-169.68-129.18-110.96-93.22-109.47
Capital Expenditures
-3.18-10.05-8.03-11.44-34.65-4.23
Free Cash Flow
-194.03-179.73-137.21-122.4-127.87-113.69
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-6983.29%-3653.76%-3358.55%-3224.07%-4571.61%-19342.30%
Pretax Margin
-2275.57%-3385.38%-3479.61%-3097.76%-4004.53%13523.87%
Profit Margin
-2275.57%-3385.38%-3479.61%-3097.76%-4004.53%13523.90%
FCF Margin
-4711.63%-3583.87%-3144.04%-3266.72%-4946.65%-25606.50%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
PE Ratio
-----37.44
Forward PE
-129.14260.00260.00260.00260.00
PS Ratio
369.52309.82375.22224.13433.895432.21